AMPE — Ampio Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $0.12m
- -$3.96m
Annual cashflow statement for Ampio Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.6 | -15.9 | -17.1 | -16.3 | -8.63 |
| Depreciation | |||||
| Non-Cash Items | -4.38 | 1.43 | -0.688 | -2.87 | -0.125 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.36 | -1.44 | 2.58 | -2.97 | 0.071 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -15.4 | -14.7 | -14.1 | -21.1 | -8.56 |
| Capital Expenditures | -0.022 | -0.063 | -0.097 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.022 | -0.063 | -0.097 | 0 | — |
| Financing Cash Flow Items | -1.66 | -1.37 | -2.51 | -0.111 | -0.098 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 14.4 | 25.6 | 30.7 | -0.111 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.05 | 10.8 | 16.5 | -21.2 | -8.56 |